PL2773648T3 - Związki farmaceutyczne do zastosowania w terapii zakażenia clostridium difficile - Google Patents
Związki farmaceutyczne do zastosowania w terapii zakażenia clostridium difficileInfo
- Publication number
- PL2773648T3 PL2773648T3 PL12772882T PL12772882T PL2773648T3 PL 2773648 T3 PL2773648 T3 PL 2773648T3 PL 12772882 T PL12772882 T PL 12772882T PL 12772882 T PL12772882 T PL 12772882T PL 2773648 T3 PL2773648 T3 PL 2773648T3
- Authority
- PL
- Poland
- Prior art keywords
- therapy
- clostridium difficile
- pharmaceutical compounds
- difficile infection
- infection
- Prior art date
Links
- 208000037384 Clostridium Infections Diseases 0.000 title 1
- 206010009657 Clostridium difficile colitis Diseases 0.000 title 1
- 206010054236 Clostridium difficile infection Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C305/00—Esters of sulfuric acids
- C07C305/20—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/093—Polyol derivatives esterified at least twice by phosphoric acid groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/207—Cyclohexane rings not substituted by nitrogen atoms, e.g. kasugamycins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11007933 | 2011-09-29 | ||
| EP11007935 | 2011-09-29 | ||
| EP12772882.2A EP2773648B1 (en) | 2011-09-29 | 2012-09-28 | Pharmaceutical compounds for use in the therapy of clostridium difficile infection |
| PCT/EP2012/004088 WO2013045107A1 (en) | 2011-09-29 | 2012-09-28 | Pharmaceutical compounds for use in the therapy of clostridium difficile infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2773648T3 true PL2773648T3 (pl) | 2020-03-31 |
Family
ID=47022623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12772882T PL2773648T3 (pl) | 2011-09-29 | 2012-09-28 | Związki farmaceutyczne do zastosowania w terapii zakażenia clostridium difficile |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9358243B2 (pl) |
| EP (2) | EP2773648B1 (pl) |
| JP (1) | JP5766884B2 (pl) |
| CN (2) | CN105949234B (pl) |
| AU (2) | AU2012314932B2 (pl) |
| BR (1) | BR112014007405B1 (pl) |
| CA (1) | CA2849426C (pl) |
| DK (1) | DK2773648T3 (pl) |
| EA (1) | EA024069B1 (pl) |
| ES (1) | ES2727633T3 (pl) |
| IL (1) | IL231698A (pl) |
| MX (1) | MX347723B (pl) |
| PL (1) | PL2773648T3 (pl) |
| WO (1) | WO2013045107A1 (pl) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2054044B1 (de) * | 2006-08-02 | 2014-07-23 | Johannes Gutenberg-Universität Mainz | Arzneimittel gegen lct-vergiftungen |
| CN108367080B (zh) * | 2015-12-11 | 2021-10-08 | 苏黎世联邦理工学院 | 用于病理性结晶的肌醇衍生物 |
| US11028112B2 (en) | 2015-12-11 | 2021-06-08 | Eth Zurich | Inositol derivatives for use in pathological crystallization |
| US11707470B2 (en) | 2015-12-11 | 2023-07-25 | Eth Zurich | Inositol derivatives for use in pathological crystallization |
| JP6893037B2 (ja) * | 2015-12-11 | 2021-06-23 | エーテーハー・チューリッヒＥＴＨ Ｚｕｒｉｃｈ | Ｃ．ｄｉｆｆｉｃｉｌｅ感染のための４，６−ジ−（Ｏ−チオホスフェート）−イノシトール−１，２，３，５−テトラ−Ｏ−スルフェート |
| CN106474458B (zh) * | 2017-01-05 | 2020-03-24 | 重庆医科大学 | 白介素-27在治疗艰难梭菌感染中的应用 |
| EP3852767B1 (en) * | 2018-09-18 | 2025-12-17 | Vifor (International) AG | Calcium oxalate crystallization inhibitors for renal disorders |
| KR102683836B1 (ko) | 2018-10-11 | 2024-07-09 | 사니핏 테라퓨틱스 에스.에이. | 이소성 석회화의 치료를 위한 이노시톨 포스페이트 |
| KR20210148078A (ko) | 2019-01-30 | 2021-12-07 | 사니핏 테라퓨틱스 에스.에이. | 조직 관류 증가에 사용하기 위한 이노시톨 포스페이트 화합물 |
| EP3818983A1 (en) | 2019-11-11 | 2021-05-12 | Sanifit Therapeutics S.A. | Inositol phosphate compounds for use in treating, inhibiting the progression, or preventing cardiovascular calcification |
| WO2021219135A1 (zh) * | 2020-04-30 | 2021-11-04 | 上海森辉医药有限公司 | 一种肌醇衍生物及其用途 |
| JP2023551660A (ja) * | 2020-11-20 | 2023-12-12 | ヴィフォール （インターナショナル） アーゲー | 石灰化関連腎臓病の治療をするためのイノシトールヘキサキスリン酸アナログ |
| EP4015494A1 (en) | 2020-12-15 | 2022-06-22 | Sanifit Therapeutics S.A. | Processes for the preparation of soluble salts of inositol phosphates |
| AU2022214904A1 (en) | 2021-01-26 | 2023-07-06 | Vifor (International) Ag | Clinical dosing schedule of inositol phosphate oligo(ethylene glycol) compounds |
| WO2024047037A1 (en) | 2022-08-30 | 2024-03-07 | ETH Zürich | Compositions for parenteral sustained release delivery of hydrophilic drugs |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5444901A (en) | 1977-09-12 | 1979-04-09 | Ricoh Kk | Treating liquid for flat printing plate |
| SE8605063D0 (sv) * | 1986-11-26 | 1986-11-26 | Matti Siren | Derivatives of cyclohexane |
| GB8705811D0 (en) * | 1987-03-11 | 1987-04-15 | Research Corp Ltd | Inositol derivatives |
| EP2054044B1 (de) * | 2006-08-02 | 2014-07-23 | Johannes Gutenberg-Universität Mainz | Arzneimittel gegen lct-vergiftungen |
| DE102006062250A1 (de) * | 2006-12-22 | 2008-06-26 | Roland Saur-Brosch | Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden |
| US8809392B2 (en) * | 2008-03-28 | 2014-08-19 | Ecolab Usa Inc. | Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents |
| WO2010049921A1 (en) | 2008-10-31 | 2010-05-06 | Alimentary Health Limited | Disaccharides |
| US20120258936A1 (en) * | 2011-04-06 | 2012-10-11 | The Board Of Regents Of The University Of Texas System | Inositol hexakisphosphate analogs and uses thereof |
-
2012
- 2012-09-28 WO PCT/EP2012/004088 patent/WO2013045107A1/en not_active Ceased
- 2012-09-28 EP EP12772882.2A patent/EP2773648B1/en active Active
- 2012-09-28 US US14/347,649 patent/US9358243B2/en active Active
- 2012-09-28 BR BR112014007405-4A patent/BR112014007405B1/pt active IP Right Grant
- 2012-09-28 ES ES12772882T patent/ES2727633T3/es active Active
- 2012-09-28 PL PL12772882T patent/PL2773648T3/pl unknown
- 2012-09-28 MX MX2014003771A patent/MX347723B/es active IP Right Grant
- 2012-09-28 JP JP2014532277A patent/JP5766884B2/ja active Active
- 2012-09-28 AU AU2012314932A patent/AU2012314932B2/en active Active
- 2012-09-28 EP EP19162400.6A patent/EP3521294A1/en not_active Withdrawn
- 2012-09-28 DK DK12772882.2T patent/DK2773648T3/da active
- 2012-09-28 CN CN201610286773.XA patent/CN105949234B/zh active Active
- 2012-09-28 EA EA201490726A patent/EA024069B1/ru not_active IP Right Cessation
- 2012-09-28 CA CA2849426A patent/CA2849426C/en active Active
- 2012-09-28 CN CN201280058049.1A patent/CN103958535A/zh active Pending
-
2014
- 2014-03-25 IL IL231698A patent/IL231698A/en active IP Right Grant
-
2017
- 2017-04-12 AU AU2017202419A patent/AU2017202419B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| MX347723B (es) | 2017-05-10 |
| CA2849426C (en) | 2020-03-24 |
| AU2017202419A1 (en) | 2017-05-11 |
| JP2014532049A (ja) | 2014-12-04 |
| US9358243B2 (en) | 2016-06-07 |
| EP2773648B1 (en) | 2019-03-13 |
| ES2727633T3 (es) | 2019-10-17 |
| EP2773648A1 (en) | 2014-09-10 |
| IL231698A (en) | 2017-06-29 |
| US20140235590A1 (en) | 2014-08-21 |
| BR112014007405A2 (pt) | 2017-04-04 |
| EA024069B1 (ru) | 2016-08-31 |
| CN105949234A (zh) | 2016-09-21 |
| WO2013045107A1 (en) | 2013-04-04 |
| CN105949234B (zh) | 2018-07-10 |
| CN103958535A (zh) | 2014-07-30 |
| CA2849426A1 (en) | 2013-04-04 |
| EP3521294A1 (en) | 2019-08-07 |
| NZ624189A (en) | 2015-05-29 |
| AU2012314932B2 (en) | 2017-01-19 |
| JP5766884B2 (ja) | 2015-08-19 |
| AU2017202419B2 (en) | 2017-08-31 |
| MX2014003771A (es) | 2015-03-20 |
| EA201490726A1 (ru) | 2014-08-29 |
| AU2012314932A1 (en) | 2014-05-15 |
| DK2773648T3 (da) | 2019-05-20 |
| BR112014007405B1 (pt) | 2021-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2773648T3 (pl) | Związki farmaceutyczne do zastosowania w terapii zakażenia clostridium difficile | |
| ZA201407726B (en) | Pharmaceutical compositions for combination therapy | |
| IL227496A0 (en) | Derivatives of the azaindazole or diazaindazole types as medicine | |
| EP2739144A4 (en) | COMPOUNDS AND ITS THERAPEUTIC USE | |
| GB201117313D0 (en) | Bacterium for use in medicine | |
| GB201114212D0 (en) | Therapeutic agents | |
| SG10201604667YA (en) | Pharmaceutical preparation | |
| SI2691083T1 (sl) | Farmacevtski sestavek sitagliptina | |
| IL232305A0 (en) | pharmaceutical preparations | |
| EP2671605A4 (en) | NEEDLESS SYRINGE | |
| GB2525835B (en) | Pharmaceutical agent | |
| IL229591A0 (en) | Addition of medicine | |
| LT2814473T (lt) | Farmacinės kompozicijos, skirtos derinių terapijai | |
| PL2723344T3 (pl) | Złożony środek leczniczy zawierający monoterpen | |
| GB201105298D0 (en) | Pharmaceutical preparation | |
| SG11201402226PA (en) | Therapeutic agent for arthrosis | |
| EP2701735A4 (en) | LIQUID VACCINE COMPOSITIONS | |
| PL2691119T3 (pl) | Preparat farmaceutyczny | |
| HUP1100245A2 (en) | Pharmaceutical composition for the treatment of wounds | |
| GB201104632D0 (en) | Use of medicament | |
| GB201108234D0 (en) | Pharmaceutical agent | |
| HUE043019T2 (hu) | Gyógyszerészeti készítmények kombinációs terápia céljára | |
| GB201110895D0 (en) | Therapeutic use | |
| AU2011900519A0 (en) | Drug compositions for the treatment of insomnia | |
| GB201106985D0 (en) | Compounds for the treatment of clostridium difficile associated disease |